Welcome to LookChem.com Sign In|Join Free

CAS

  • or

918653-13-1

Post Buying Request

918653-13-1 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

918653-13-1 Usage

Description

3,9-Diazaspiro[5.5]undecane-3-carboxylic acid, 9-methyl-, 1,1-dimethylethyl ester is a unique chemical compound characterized by a spiro ring and a carboxylic acid functionality. It is derived from 3,9-diazaspiro[5.5]undecane-3-carboxylic acid, 9-methyl, and is known for its stability and enhanced solubility and bioavailability due to the 1,1-dimethylethyl ester group attached to the carboxylic acid. 3,9-Diazaspiro[5.5]undecane-3-carboxylic acid, 9-methyl-, 1,1-dimethylethyl ester serves as a valuable building block in organic synthesis and has a wide range of applications in the chemical and pharmaceutical industries.

Uses

Used in Pharmaceutical Industry:
3,9-Diazaspiro[5.5]undecane-3-carboxylic acid, 9-methyl-, 1,1-dimethylethyl ester is used as an intermediate in the synthesis of various pharmaceuticals. Its unique structure and properties make it a useful building block for the development of new drugs and therapeutic agents.
Used in Agrochemical Industry:
In the agrochemical industry, 3,9-Diazaspiro[5.5]undecane-3-carboxylic acid, 9-methyl-, 1,1-dimethylethyl ester is utilized as a key component in the production of agrochemicals, such as pesticides and herbicides. Its stability and bioavailability contribute to the effectiveness of these products.
Used in Specialty Chemicals:
3,9-Diazaspiro[5.5]undecane-3-carboxylic acid, 9-methyl-, 1,1-dimethylethyl ester is also employed in the production of specialty chemicals, where its unique structure and properties are leveraged to create high-performance materials for various applications.
Used in Drug Discovery and Development:
Due to its unique structure and properties, 3,9-Diazaspiro[5.5]undecane-3-carboxylic acid, 9-methyl-, 1,1-dimethylethyl ester serves as a useful tool in drug discovery and development. It can be used to explore new chemical entities and optimize the properties of existing compounds, ultimately contributing to the advancement of novel therapeutic agents.

Check Digit Verification of cas no

The CAS Registry Mumber 918653-13-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,1,8,6,5 and 3 respectively; the second part has 2 digits, 1 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 918653-13:
(8*9)+(7*1)+(6*8)+(5*6)+(4*5)+(3*3)+(2*1)+(1*3)=191
191 % 10 = 1
So 918653-13-1 is a valid CAS Registry Number.
InChI:InChI=1/C15H28N2O2/c1-14(2,3)19-13(18)17-11-7-15(8-12-17)5-9-16(4)10-6-15/h5-12H2,1-4H3

918653-13-1SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name 3,9-Diazaspiro[5.5]undecane-3-carboxylic acid, 9-methyl-, 1,1-dimethylethyl ester

1.2 Other means of identification

Product number -
Other names 9-methyl-3,4,6,7,9,10-hexahydro-2H,5H-acridine-1,8-dione

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:918653-13-1 SDS

918653-13-1Downstream Products

918653-13-1Relevant articles and documents

NOVEL SULFONAMIDE DERIVATIVE WITH FUSED PYRIMIDINE SKELETON, HAVING EPIDERMAL GROWTH FACTOR RECEPTOR MUTATION INHIBITORY EFFECT

-

Paragraph 0098; 0099, (2021/07/02)

The present invention relates to a novel fused pyrimidine based sulfonamide derivative represented by Formula I, a solvate thereof, or a pharmaceutically acceptable salt thereof, and a pharmaceutical composition including the same as an active ingredient. The novel fused pyrimidine based sulfonamide derivative of the present invention can effectively suppress the growth of cancer cells and resistance to drugs, which are induced by mutations in the tyrosine kinase domain of epidermal growth factor receptors, or the growth of cancer cells having such resistance.

Spiro aryl phosphorus oxide or sulfide

-

Paragraph 0620; 0621; 0622; 0623, (2016/10/08)

The invention discloses a spiro aryl phosphorus oxide or sulfide as ALK inhibitor, and in particular discloses a compound shown in a formula (I) as an ALK inhibitor or a pharmaceutically acceptable salt thereof.

Novel compounds useful for bradykinin B1 receptor antagonism

-

Page/Page column 35, (2010/11/25)

Disclosed are compounds that are bradykinin B1 receptor antagonists and are useful for treating diseases, or relieving adverse symptoms associated with disease conditions, in mammals mediated by bradykinin B1 receptor.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 918653-13-1